InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,517.20
(
0.53%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
73.12
(
-0.10%
)
Bitcoin
63,230.87
(
0.15%
)
Post# of 253225
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120502
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Thursday, 09/18/2014 10:35:54 AM

Thursday, September 18, 2014 10:35:54 AM

Post# of 253225
ProQR Therapeutics (PRQR) IPOs 8.6M* shares @$13.00 and is already +51% in the first hour:

http://finance.yahoo.com/news/proqr-announces-pricing-initial-public-120727024.html

[ProQR is] an innovative biopharmaceutical company engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis. Utilizing our unique, proprietary RNA repair technologies, we believe we will be able to treat genetic disorders in which a single protein is defective due to certain types of genetic mutation. We believe that this is a unique approach that offers advantages compared with small molecule, gene therapy and other therapeutic strategies.

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up